Amanda Becerra

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

T. Kohlsdorf, A. Fabro, F. Cunha, 2020, The Journal of experimental medicine.

Inflammasome activation in COVID-19 patients

T. Kohlsdorf, A. Fabro, F. Cunha, 2020, medRxiv.

Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells

H. Nakaya, A. Fabro, J. Alves-Filho, 2022, eLife.

Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection

A. Fabro, P. Louzada-Junior, Tamara S. Rodrigues, 2022, Science advances.

Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells

A. Fabro, F. Cunha, J. Alves-Filho, 2021, medRxiv.

CASP4/11 contributes to NLRP3 activation and COVID-19 exacerbation.

A. Fabro, G. F. Gomes, P. Louzada-Junior, 2023, The Journal of infectious diseases.

Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: Positive and negative effects

Ye Han, C. Khodr, Amanda Becerra, 2014, Brain Research.

Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19.

S. Batah, D. Wada, Samuel Oliveira, 2024, PLoS Pathogens.